Whitepaper: How protein biomarkers can impact cancer outcomes
Download this whitepaper by Standard BioTools to learn about the tumour microenvironment (TME) and the protein biomarkers helping to shape cancer outcomes.
The tumour microenvironment (TME) is no longer considered a passive backdrop to cancer. It is a dynamic ecosystem that plays a central role in tumour growth, immune suppression, metastasis and treatment resistance.
Whitepaper highlights:
- Understand how the TME drives cancer progression, immune evasion and therapeutic resistance
- Explore emerging strategies that target the TME to improve cancer therapy outcomes
- Discover how proteomic technologies provide complementary insights across molecular, cellular and spatial levels
- Learn how characterising the TME can reveal prognostic biomarkers and mechanisms of treatment response or failure
Download it here
